TRONCI, ELISABETTA
 Distribuzione geografica
Continente #
EU - Europa 85.143
NA - Nord America 3.858
AS - Asia 1.391
SA - Sud America 201
Continente sconosciuto - Info sul continente non disponibili 183
AF - Africa 39
OC - Oceania 3
Totale 90.818
Nazione #
IT - Italia 84.220
US - Stati Uniti d'America 3.801
SG - Singapore 550
CN - Cina 477
UA - Ucraina 245
DE - Germania 208
SE - Svezia 174
BR - Brasile 161
VN - Vietnam 115
FI - Finlandia 84
GB - Regno Unito 71
FR - Francia 63
HK - Hong Kong 52
KR - Corea 43
IN - India 37
CA - Canada 34
RU - Federazione Russa 22
IQ - Iraq 21
AR - Argentina 18
BD - Bangladesh 16
JP - Giappone 16
BE - Belgio 11
NL - Olanda 11
MX - Messico 10
PK - Pakistan 10
ZA - Sudafrica 10
CZ - Repubblica Ceca 8
ES - Italia 8
ID - Indonesia 8
KE - Kenya 8
TR - Turchia 8
CL - Cile 7
AE - Emirati Arabi Uniti 6
EG - Egitto 6
SA - Arabia Saudita 6
MA - Marocco 5
EC - Ecuador 4
JM - Giamaica 4
PL - Polonia 4
TH - Thailandia 4
CO - Colombia 3
EU - Europa 3
MY - Malesia 3
PY - Paraguay 3
TN - Tunisia 3
VE - Venezuela 3
AT - Austria 2
AU - Australia 2
BG - Bulgaria 2
DZ - Algeria 2
GT - Guatemala 2
IE - Irlanda 2
JO - Giordania 2
KH - Cambogia 2
KZ - Kazakistan 2
NI - Nicaragua 2
OM - Oman 2
SN - Senegal 2
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BB - Barbados 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DK - Danimarca 1
GE - Georgia 1
HN - Honduras 1
IL - Israele 1
KG - Kirghizistan 1
LB - Libano 1
LK - Sri Lanka 1
LT - Lituania 1
LV - Lettonia 1
LY - Libia 1
MN - Mongolia 1
MT - Malta 1
NZ - Nuova Zelanda 1
PA - Panama 1
PH - Filippine 1
RO - Romania 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 90.638
Città #
Cagliari 80.609
Uta 3.423
Fairfield 420
Woodbridge 360
Ashburn 340
Singapore 269
Chandler 212
Ann Arbor 201
San Jose 189
Houston 183
Wilmington 180
Seattle 152
Cambridge 151
Jacksonville 128
Nyköping 126
Boardman 118
Beijing 117
Dallas 117
Dearborn 108
Council Bluffs 62
Los Angeles 56
Shanghai 55
Nanjing 53
Santa Clara 52
Hong Kong 45
Ho Chi Minh City 42
The Dalles 42
Helsinki 41
New York 41
Seoul 40
Lauterbourg 37
Milan 25
Boston 23
Hefei 23
Hanoi 22
San Diego 22
Munich 17
Buffalo 14
Guangzhou 14
São Paulo 14
Tokyo 13
Dong Ket 12
Tianjin 12
Brussels 11
Changsha 11
Nanchang 11
Redwood City 11
Shenyang 11
Verona 11
Frankfurt am Main 10
Mountain View 10
Toronto 10
Hebei 9
Sassari 9
Brooklyn 8
London 8
Montreal 8
Norwalk 8
Orem 8
Oristano 8
Phoenix 8
Redondo Beach 8
Baghdad 7
Chennai 7
Chicago 7
Falls Church 7
Hangzhou 7
Nairobi 7
New Delhi 7
San Francisco 7
Turku 7
Washington 7
Brno 6
Columbus 6
Da Nang 6
Jinan 6
Johannesburg 6
Padova 6
Rome 6
Atlanta 5
Central 5
Detroit 5
Stockholm 5
Ankara 4
Edinburgh 4
Florence 4
Grottammare 4
Jiaxing 4
Kingston 4
Lahore 4
Ningbo 4
Orange 4
Pune 4
Zhengzhou 4
Amsterdam 3
Belo Horizonte 3
Betim 3
Biên Hòa 3
Borås 3
Brasília 3
Totale 88.552
Nome #
5alpha-reductase inhibitors dampen L-DOPA-induced dyskinesia via normalization of dopamine D1-receptor signaling pathway and D1-D3 receptor interaction 5.833
Effect of memantine on L-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson's disease. 4.345
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease 4.300
The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's disease 4.088
Anti-dyskinetic effect of anpirtoline in animal models of L-DOPA-induced dyskinesia 3.697
Effect of selective and non-selective serotonin receptor activation on l-DOPA-induced therapeutic efficacy and dyskinesia in parkinsonian rats 3.588
Antidyskinetic effect of A2A and 5HT1A/1B receptor ligands in two animal models of Parkinson's disease 3.553
The anti-dyskinetic effect of dopamine receptor blockade is enhanced in parkinsonian rats following dopamine neuron transplantation 3.472
null 2.940
Vitamin A deficiency induces motor impairments and striatal cholinergic dysfunction in rats 2.879
Study of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia 2.589
The serotonergic system in levodopa-induced dyskinesia 2.571
Efficacy and safety of 5-Hydroxytryptophan on levodopa-induced motor complications in Parkinson's disease: A preliminary finding 2.370
null 2.298
5-HT1 receptor agonists for the treatment of L-DOPA-induced dyskinesia: From animal models to clinical investigation 2.254
null 2.247
Foetal cell transplantation for Parkinson's disease: focus on graft-induced dyskinesia 2.200
Serotonin system implication in L-DOPA-induced dyskinesia: from animal models to clinical investigations 2.184
Role of serotonin neurons in L-DOPA- and graft-induced dyskinesia in a rat model of parkinson's disease 2.181
Amphetamine-induced rotation and L-DOPA-induced dyskinesia in the rat 6-OHDA model: A correlation study 2.166
A new ethyladenine antagonist of adenosine A(2A) receptors: behavioral and biochemical characterization as an antiparkinsonian drug 2.114
Caffeine consumption and changes in the function of dopaminergic transmission: evidence of a hyperdopaminergic state in rats subchronically treated with caffeine 1.801
Serotonin neuron-dependent and -independent reduction of dyskinesia by 5-HT1A and5-HT1B receptor agonists in the rat Parkinson model 1.554
null 1.471
BDNF Overexpression Increases Striatal D3Receptor Level at Striatal Neurons and Exacerbates D1-Receptor Agonist-Induced Dyskinesia 1.413
Long-term increase in GAD67 mRNA expression in the central amygdala of rats sensitized by drugs and stress 1.319
Characterization of the antiparkinsonian effects of the new adenosine A2A receptor antagonist ST1535: acute and subchronic studies in rats 1.293
Caffeine sensitization and cross-sensitization with amphetamine: association to post-synaptic changes in rat striatal neurons 1.249
null 1.194
Adenosine A2A and dopamine receptor interactions in basal ganglia of dopamine denervated rats 1.180
Dopamine and adenosine receptor interaction as the basis for the treatment of Parkinson's disease 1.128
Effect of serotonin transporter blockade on L-DOPA-induced dyskinesia in animal models of Parkinson's disease 1.100
Modulation of serotonergic transmission by eltoprazine in L-DOPA-induced dyskinesia: Behavioral, molecular, and synaptic mechanisms 1.093
Dopamine and adenosine receptor interaction as basis for the treatment of Parkinson's disease 1.081
CAFFEINE SESITIZATION AND CROSS-SENSITIZATION WITH AMPHETAMINE: ASSOCIATION TO POST-SYNAPTIC CHANGES IN RAT STRIATAL NEURONS 1.055
CAFFEINE SENSITIZATION AND CROSS-SENSITIZATION WITH AMPHETAMINE: ASSOCIATION TO POST BUT NOT PRE-SYNAPTIC CHANGES IN RAT STRIATAL NEURON 1.048
null 1.012
Changes in the expression of tonic and phasic neurochemical markers of activity in a rat model of L-DOPA induced dyskinesia 987
null 967
Changes in the expression of tonic and phasic neurochemical markers of activity in a rat model of L-DOPA induced dynskinesia 963
Selective modifications in GAD67 mRNA levels in striatonigral and striatopallidal pathways correlate to dopamine agonist priming in 6-hydroxydopamine-lesioned rats 934
5-Hydroxy-tryptophan for the treatment of l-DOPA-induced dyskinesia in the rat Parkinson's disease model 905
Different responsiveness of striatonigral and striatopallidal neurons to L-DOPA after a subchronic intermittent L-DOPA treatment 881
BDNF over-expression induces striatal serotonin fiber sprouting and increases the susceptibility to L-DOPA-induced dyskinesia in 6-OHDA-lesioned rats 707
Potentiation of amphetamine-mediated responses in caffeine-sensitized rats involves modifications in A2A receptors and zif-268 mRNAs in striatal neurons 326
Subchronic-intermittent caffeine amplifies the motor effects of amphetamine in rats 288
Totale 90.818
Categoria #
all - tutte 109.518
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 109.518


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.198 0 366 173 182 253 273 204 158 271 431 492 395
2022/20235.396 358 594 582 451 475 603 302 358 408 422 567 276
2023/20245.792 231 177 232 295 539 859 907 389 223 409 613 918
2024/202517.280 4.890 4.650 4.172 1.181 592 638 702 55 129 76 90 105
2025/20262.654 194 95 259 216 184 174 701 135 175 273 165 83
2026/2027133 54 79 0 0 0 0 0 0 0 0 0 0
Totale 90.818